Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

The Association between Tricuspid Regurgitation Velocity and Pulmonary Embolism in Sickle Cell Disease: A Retrospective Cohort Analysis

Mariam Michel Kalds, Kristin Wuichet, Mark Rodeghier, Michael R. DeBaun

Blood (2024) 144 (Supplement 1): 4026.

https://doi.org/10.1182/blood-2024-200926

Published: 2024

Journal Articles

Assessing Primary Stroke Prevention Barriers and Facilitators in Children with Sickle Cell Anemia in Puerto Rico: A Mixed Methods Study Design

Gabriela Ramirez Cuebas, Jose A. Mejias, Exa Mejías Ramos, Keishla Figueroa Colón, Mark Rodeghier, Rosa Diaz Torres, Allison A. King, Michael R. DeBaun

Blood (2024) 144 (Supplement 1): 4998.

https://doi.org/10.1182/blood-2024-200097

Published: 2024

Journal Articles

Characterizing Death in Sickle Cell Disease in a National EHR Database: A Population Analysis

Gerard Hills, Harlan Nelson, Shaun Grannis, Michael R. DeBaun

Blood (2024) 144 (Supplement 1): 3685.

https://doi.org/10.1182/blood-2024-201120

Published: 2024

Journal Articles

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Blood (2024) 143 (25): 2654–2665.

https://doi.org/10.1182/blood.2023023301

Published: 2024

Includes: Supplemental data

Journal Articles

Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

Blood (2023) 142 (Supplement 2): LBA-4.

https://doi.org/10.1182/blood-2023-192022

Published: 2023

Journal Articles

Assessing Pain Severity in Sickle Cell Disease Using Animations and a Graphical Body Image

Blood (2023) 142 (Supplement 1): 5052.

https://doi.org/10.1182/blood-2023-189667

Published: 2023

Journal Articles

A Randomized Clinical Trial Testing the Effect of Digital Behavioral Interventions on Pain and Mental Health Among Adults with Sickle Cell Disease

Blood (2023) 142 (Supplement 1): 789.

https://doi.org/10.1182/blood-2023-186763

Published: 2023

Journal Articles

Localization of Silent Cerebral Infarcts in Children with Sickle Cell Disease Impacts Structural Disconnection

Amy Mirro, Michael M. Binkley, Landon C. Power, Kristin P. Guilliams, Slim Fellah, Michael R. DeBaun, Andria L. Ford, Jin-Moo Lee, Melanie E. Fields

Blood (2023) 142 (Supplement 1): 2488.

https://doi.org/10.1182/blood-2023-188230

Published: 2023

Journal Articles

Characterization of Sickle Cell Disease Mortality in a National Electronic Health Record (EHR) System

Gerard Hills, Kristin Wuichet, Harlan Nelson, Robert Cronin, Shaun Grannis, Michael R. DeBaun

Blood (2023) 142 (Supplement 1): 5332.

https://doi.org/10.1182/blood-2023-190257

Published: 2023

Journal Articles

The Optimal Threshold for Hemoglobin S Percent Level While Performing Regular Blood Transfusion Therapy to Prevent Severe Vaso-Occlusive Pain Events in Children with Sickle Cell Anemia: A Secondary Data Analysis of Participants in the SIT Trial

Jose A. Mejias, Alejandro R. Gonzalez-Barreto, Mark Rodeghier, Michael R. DeBaun

Blood (2023) 142 (Supplement 1): 2523.

https://doi.org/10.1182/blood-2023-185173

Published: 2023

Journal Articles

Randomized Controlled Double Blind Feasibility Trial of Tadalafil with Hydroxyurea Versus Hydroxyurea with Placebo for Secondary Prevention of Recurrent Priapism in Men with Sickle Cell Anemia: Pin Trial Final Results

Ibrahim Musa Idris, Aminu Abba Yusuf, Ismail Ismail, Awwal Musa Borodo, Kabiru Musangedu, Tukur Aliyu, Datti Alfa, Mustapha Shuaiabu Hikima, Mohammad Suwaid, Shehu Kana, Sani Aji, Aisha Kuliya Gwarzo, Kabiru Bello Muhammad, Jamil Aliyu Galadanci, Rukayya Alkassim, Nafiu Hussaini, Mark Rodeghier, Arthur Burnett, Michael R. DeBaun

Blood (2023) 142 (Supplement 1): 2531.

https://doi.org/10.1182/blood-2023-190396

Published: 2023

Journal Articles

The Importance of Screening for Food Insecurity in Children with Sickle Cell Anemia: An Ancillary Study to the Severe Acute Malnutrition Feasibility Trial in Nigeria

Gabriela Ramirez Cuebas, Shehu Umar Abdullahi, Safiya Gambo, Hassan Adam Murtala, Halima Kabir, Khadija A. Shamsu, Garba Gwarzo, Sari A Acra, Virginia Stallings, Mark Rodeghier, Michael R. DeBaun, Lauren J Klein

Blood (2023) 142 (Supplement 1): 2511.

https://doi.org/10.1182/blood-2023-182833

Published: 2023

Journal Articles

In Phase 2 and Phase 3 Trials, Broadening the Definition of Acute Vaso-Occlusive Pain to Include at Least One Episode of Pain Requiring Nsaids, Opioids, or Both Treatments at Home within 30 Days of a Physician Visit

Alejandro R. Gonzalez-Barreto, Jose A. Mejias, Michael R. DeBaun

Blood (2023) 142 (Supplement 1): 5333.

https://doi.org/10.1182/blood-2023-190306

Published: 2023

Journal Articles

A Working Definition of Acute Chest Syndrome without the Requirement of Chest X-Rays

Alejandro R. Gonzalez-Barreto, Jose A. Mejias, Michael R. DeBaun, Eugenia Vicky Asare, Samuel A. Oppong

Blood (2023) 142 (Supplement 1): 5337.

https://doi.org/10.1182/blood-2023-191001

Published: 2023

Journal Articles

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

Blood (2023) 142 (Supplement 1): 146.

https://doi.org/10.1182/blood-2023-179042

Published: 2023

Journal Articles

A Genotype Validated Bimodal Method for the Large-Scale Identification and Phenotyping of Persons with Sickle Cell Disease Using Electronic Health Record Data

Kristin Wuichet, Clifford M Takemoto, Robert Cronin, Martha Barton, Pei-Lin Chen, Santosh L. Saraf, Mitchell J. Weiss, Michael R. DeBaun

Blood (2023) 142 (Supplement 1): 7164.

https://doi.org/10.1182/blood-2023-190521

Published: 2023

Journal Articles

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial

Shehu U. Abdullahi, Surayya Sunusi, Mohammed Sani Abba, Saifuddeen Sani, Hauwau Aminu Inuwa, Safiya Gambo, Awwal Gambo, Bilya Musa, Brittany V. Covert Greene, Adetola A. Kassim, Mark Rodeghier, Nafiu Hussaini, Mariana Ciobanu, Muktar H. Aliyu, Lori C. Jordan, Michael R. DeBaun

Blood (2023) 141 (8): 825–834.

https://doi.org/10.1182/blood.2022016620

Published: 2023

Includes: Supplemental data

Journal Articles

Interim Analysis of a Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Sickle Cell Disease Patients with Priapism (SPARTAN)

Alan Anderson, Fuad El Rassi, Michael R. DeBaun, Modupe Idowu, Julie Kanter, Soheir Adam, Susanna Curtis, Darla Liles, Biree Andemariam, Morgan L. McLemore, Robert Sheppard Nickel, Poornima Ramadas, Jincy Paulose, Dramane I Laine, Mahmudul Khan, Deepika S. Darbari, Arthur L. Burnett

Blood (2022) 140 (Supplement 1): 1636–1638.

https://doi.org/10.1182/blood-2022-157004

Published: 2022

Journal Articles

Progressive Silent Cerebral Infarcts Are Prevalent in Adults with Sickle Cell Anemia but Moderate-Severe Cognitive Abnormalities Are Independent of Preexisting Silent Cerebral Infarcts

Ibrahim Musa Idris, Dalha H Gwarzo, Shamsu Iguda, Faruk Aminu, Mustapha Shuaibu Hikima, Mohammed Kabir Saleh, Mohammad Abba Suwaid, Aliyu Ibrahim, Hauwa Ibrahim, Shehu Kana, Rabia Abubakar Haruna, Jamil Aliyu Galadanci, Nafiu Hussain, Mark Rodeghier, Hyacinth I Hyacinth, Allison A. King, Michael R. DeBaun

Blood (2022) 140 (Supplement 1): 1629–1631.

https://doi.org/10.1182/blood-2022-169460

Published: 2022

Journal Articles

Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition

Jia Yu, Jenna Brown, Eli Salzberg, Aria Wei, Gloria Gerber, Xiang-Zuo Pan, Alison R. Moliterno, MIchael B. Streiff, Peggy Kraus, Claire Logue, Jennifer Yui, Rakhi P.P. Naik, Hira Latif, Sophie M. Lanzkron, Evan M. Braunstein, Robert Brodsky, Michael R. DeBaun, Doris Lin, Shruti Chaturvedi

Blood (2022) 140 (Supplement 1): 338–340.

https://doi.org/10.1182/blood-2022-167054

Published: 2022

NARROW

The Association between Tricuspid Regurgitation Velocity and Pulmonary Embolism in Sickle Cell Disease: A Retrospective Cohort Analysis

Assessing Primary Stroke Prevention Barriers and Facilitators in Children with Sickle Cell Anemia in Puerto Rico: A Mixed Methods Study Design

Characterizing Death in Sickle Cell Disease in a National EHR Database: A Population Analysis

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

Assessing Pain Severity in Sickle Cell Disease Using Animations and a Graphical Body Image

A Randomized Clinical Trial Testing the Effect of Digital Behavioral Interventions on Pain and Mental Health Among Adults with Sickle Cell Disease

Localization of Silent Cerebral Infarcts in Children with Sickle Cell Disease Impacts Structural Disconnection

Characterization of Sickle Cell Disease Mortality in a National Electronic Health Record (EHR) System

The Optimal Threshold for Hemoglobin S Percent Level While Performing Regular Blood Transfusion Therapy to Prevent Severe Vaso-Occlusive Pain Events in Children with Sickle Cell Anemia: A Secondary Data Analysis of Participants in the SIT Trial

Randomized Controlled Double Blind Feasibility Trial of Tadalafil with Hydroxyurea Versus Hydroxyurea with Placebo for Secondary Prevention of Recurrent Priapism in Men with Sickle Cell Anemia: Pin Trial Final Results

The Importance of Screening for Food Insecurity in Children with Sickle Cell Anemia: An Ancillary Study to the Severe Acute Malnutrition Feasibility Trial in Nigeria

In Phase 2 and Phase 3 Trials, Broadening the Definition of Acute Vaso-Occlusive Pain to Include at Least One Episode of Pain Requiring Nsaids, Opioids, or Both Treatments at Home within 30 Days of a Physician Visit

A Working Definition of Acute Chest Syndrome without the Requirement of Chest X-Rays

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

A Genotype Validated Bimodal Method for the Large-Scale Identification and Phenotyping of Persons with Sickle Cell Disease Using Electronic Health Record Data

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial

Interim Analysis of a Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Sickle Cell Disease Patients with Priapism (SPARTAN)

Progressive Silent Cerebral Infarcts Are Prevalent in Adults with Sickle Cell Anemia but Moderate-Severe Cognitive Abnormalities Are Independent of Preexisting Silent Cerebral Infarcts

Silent Cerebral Infarction during Immune TTP Remission - Prevalence, Predictors and Impact on Cognition

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only